glp-1 small molecule The chemical structures of two pyrimidine-based receptor The @NEJM just reported impressive

More recently, the SUMMIT trial demonstrated that tirzepatide reduced the composite risk of cardiovascular death or worsening heart failure by 38% (HR = 0.62, 95% CI: 0.410.95) in patients with heart failure with preserved ejection fraction (HFpEF) and a BMI 30 kg/m 2 , 32% of whom also had type 2 diabetes

Effects of testosterone treatment in older men

Both dietary supplements from MARNYS contain L-Carnitine, but in different formats and quantities

Nephrotoxicity may occur

Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during esophagogastroduodenoscopy